Science
.....
Retinal Regeneration Platform
Building a scalable platform for regenerative ophthalmology and beyond.
One Platform,
Multiple Opportunities
Celliaz’s Anti-PROX1 regenerative platform is designed
to address multiple retinal diseases exhibiting a common
Müller glial PROX1 transfer.
AMD
Age-related Macular Degeneration
RP
Retinitis Pigmentosa
Glaucoma
Future Expansion
Expanding the Future of Regenerative Medicine
From retinal regeneration to broader therapeutic opportunities.
